Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 2
1997 1
1998 2
1999 6
2000 4
2001 2
2002 3
2003 2
2004 2
2005 5
2006 2
2007 3
2008 5
2009 7
2010 3
2011 9
2012 7
2013 9
2014 13
2015 12
2016 12
2017 10
2018 11
2019 8
2020 8
2021 7
2022 6
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Sounding the alarmins-The role of alarmin cytokines in asthma.
Gauvreau GM, Bergeron C, Boulet LP, Cockcroft DW, Côté A, Davis BE, Leigh R, Myers I, O'Byrne PM, Sehmi R. Gauvreau GM, et al. Allergy. 2023 Feb;78(2):402-417. doi: 10.1111/all.15609. Epub 2022 Dec 14. Allergy. 2023. PMID: 36463491 Free PMC article. Review.
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses.
Gauvreau GM, O'Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J, FitzGerald JM, Boedigheimer M, Davis BE, Dias C, Gorski KS, Smith L, Bautista E, Comeau MR, Leigh R, Parnes JR. Gauvreau GM, et al. N Engl J Med. 2014 May 29;370(22):2102-10. doi: 10.1056/NEJMoa1402895. Epub 2014 May 20. N Engl J Med. 2014. PMID: 24846652 Free article. Clinical Trial.
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Gauvreau GM, Hohlfeld JM, FitzGerald JM, Boulet LP, Cockcroft DW, Davis BE, Korn S, Kornmann O, Leigh R, Mayers I, Watz H, Grant SS, Jain M, Cabanski M, Pertel PE, Jones I, Lecot JR, Cao H, O'Byrne PM. Gauvreau GM, et al. Eur Respir J. 2023 Mar 9;61(3):2201193. doi: 10.1183/13993003.01193-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36822634 Free PMC article. Clinical Trial.
Anti-alarmin approaches entering clinical trials.
Gauvreau GM, White L, Davis BE. Gauvreau GM, et al. Curr Opin Pulm Med. 2020 Jan;26(1):69-76. doi: 10.1097/MCP.0000000000000615. Curr Opin Pulm Med. 2020. PMID: 31408015 Review.
Allergen-induced airway responses.
Gauvreau GM, El-Gammal AI, O'Byrne PM. Gauvreau GM, et al. Eur Respir J. 2015 Sep;46(3):819-31. doi: 10.1183/13993003.00536-2015. Epub 2015 Jul 23. Eur Respir J. 2015. PMID: 26206871 Free article. Review.
Anti-alarmin asthma therapies: where do we go from here?
Sulaiman I, Gauvreau GM. Sulaiman I, et al. Among authors: gauvreau gm. J Bras Pneumol. 2023 Jul 24;49(3):e20230220. doi: 10.36416/1806-3756/e20230220. J Bras Pneumol. 2023. PMID: 37493796 Free PMC article. No abstract available.
Antialarmins for treatment of asthma: future perspectives.
Al-Sajee D, Oliveria JP, Sehmi R, Gauvreau GM. Al-Sajee D, et al. Among authors: gauvreau gm. Curr Opin Pulm Med. 2018 Jan;24(1):32-41. doi: 10.1097/MCP.0000000000000443. Curr Opin Pulm Med. 2018. PMID: 29084017 Review.
Refashioning dexpramipexole: A new horizon in eosinophilic asthma?
Cusack RP, Sulaiman I, Gauvreau GM. Cusack RP, et al. Among authors: gauvreau gm. J Allergy Clin Immunol. 2023 Nov;152(5):1092-1094. doi: 10.1016/j.jaci.2023.09.019. Epub 2023 Sep 26. J Allergy Clin Immunol. 2023. PMID: 37769877 No abstract available.
Inhaled allergen bronchoprovocation tests.
Diamant Z, Gauvreau GM, Cockcroft DW, Boulet LP, Sterk PJ, de Jongh FH, Dahlén B, O'Byrne PM. Diamant Z, et al. Among authors: gauvreau gm. J Allergy Clin Immunol. 2013 Nov;132(5):1045-1055.e6. doi: 10.1016/j.jaci.2013.08.023. Epub 2013 Oct 11. J Allergy Clin Immunol. 2013. PMID: 24119772 Review.
156 results